Below is the **final unified plan**, fully integrating the key decisions and technical insights from **answers 5–8**, expressed as a clear blueprint you can execute in your clinical trial.

---

# ✅ **Final Plan: Open-Source, Scalable CT-Based ΔFFR Estimation Pipeline**

This plan is specifically optimized for your dataset:

✔ Hundreds of **partially** segmented arteries
✔ STL available for both **lumen** and **outer wall**
✔ Goal = **ΔFFR (pressure drop across lesion)** from geometry
✔ Use **open, validated reduced-order physics**
✔ Industrial-grade **uncertainty quantification**
✔ Minimal HPC required
✔ Clinically interpretable outputs

---

## 🚀 Strategic Summary

| Component               | Choice                                                                         | Rationale                             |
| ----------------------- | ------------------------------------------------------------------------------ | ------------------------------------- |
| Modeling                | **1D reduced-order hemodynamics**                                              | Accurate for ΔP; massively scalable   |
| Solver                  | **Python implementation of Lyras model** (with optional SimVascular 1D solver) | Removes CFD bottleneck                |
| Geometry source         | **STL lumen + STL outer wall**                                                 | Enables counterfactual reconstruction |
| Healthy reference lumen | **Outer-wall–guided taper (Glagov-aware)**                                     | Most biologically plausible           |
| Boundary conditions     | **Murray flow + hyperemia** + Windkessel                                       | Matches clinical FFR physiology       |
| Output                  | ΔP, ΔFFR, **uncertainty interval**, QC flags                                   | Required for regulatory path          |
| Validation              | Invasive FFR subset + 3D CFD subset                                            | Clinical & physical credibility       |

---

## 🔬 Pipeline (6 Automated Stages)

```
STL_lumen + STL_outer
      ↓
Centerline + A(s)
      ↓
Reference A_ref(s) (outer-wall constrained)
      ↓
Estimate Q_hyperemic + microvascular R_outlet
      ↓
Compute ΔP (Lyras model)
      ↓
ΔFFR = ΔP / P_a (w/ ±CI)
```

---

## ✅ Stage-by-Stage Decisions

### **1️⃣ Centerline & Lumen Profile**

**Tool:** VMTK

Compute:

* Centerline coordinate vs length
* Lumen area A(s)
* Outer wall radius along same centerline

QC metrics:

* Min length, sampling density, self-intersections, bifurcation proximity

---

### **2️⃣ Reference (Healthy) Lumen**

Use **outer-wall scaffold** → accounts for remodeling

Steps:
1️⃣ Identify healthy segments proximally/distally
2️⃣ Fit physiologic **exponential taper**
3️⃣ Interpolate A_ref(s) **inside lesion** under constraint:
    *healthy lumen = outer wall – healthy wall thickness*
4️⃣ Monte-Carlo reconstructions for uncertainty

**Key advantage**: You uniquely have both lumen and adventitia – most papers don’t.

---

### **3️⃣ Hyperemic Flow + Boundary Conditions**

Physiologic, literature-supported defaults:

| Parameter                | Value                                      | Source                             |
| ------------------------ | ------------------------------------------ | ---------------------------------- |
| Aortic mean pressure P_a | 95–100 mmHg                                | invasively validated FFR protocols |
| Hyperemic scaling        | Q_rest × 3.5–4                             | Adenosine physiology               |
| Flow split               | Murray exponent α≈2.7–3.0                  | Coronary allometry                 |
| R_out                    | Poiseuille + 75% reduction under hyperemia | Microvascular physiology           |

Partial tree support ✅
ΔFFR does **not** require distal anatomy.

---

### **4️⃣ Reduced-Order Pressure Loss Model**

Use modern literature-validated 1D stenosis formula:

[
\Delta P = K_1 \mu\frac{L}{A_{min}^2} Q

* K_2 \rho\left(\frac{Q}{A_{min}}\right)^2
  ]

- (K_1), (K_2) calibrated on a **small invasive FFR subset**
- Blood viscosity (\mu) ≈ 0.0035–0.0040 Pa·s
- Density (\rho) ≈ 1050 kg/m³

Compute:
[
\Delta FFR = \frac{\Delta P}{P_a}
]

> **Clinically validated cutoff:**
> ΔP > ~15 mmHg ≈ invasive **FFR < 0.80**

---

### **5️⃣ Uncertainty Quantification**

Run ensembles varying:

* Healthy wall thickness (±0.2 mm)
* Flow (±20%)
* Reference lumen taper exponent (±0.005)

Report:
✅ Median
✅ 90% confidence interval
✅ QC flag if CI width >0.05 ΔFFR

---

### **6️⃣ Validation Strategy**

Three-layer evidence:

| Layer                  | N   | Purpose                         |
| ---------------------- | --- | ------------------------------- |
| Invasive FFR subset    | ≥50 | Calibrate + clinical ROC/AUC    |
| 3D CFD subset          | ≥20 | Physics validation              |
| Reproducibility subset | ≥40 | Robustness across operator/time |

Goal: AUC > 0.92 for ischemia classification

---

## 📊 Trial-Level Outputs

For each lesion:

| ID | ΔP (mmHg) | ΔFFR | CI_low | CI_high | MLA | Ref.A | QC |
| -- | --------- | ---- | ------ | ------- | --- | ----- | -- |

For whole cohort:

* ΔFFR distribution
* Performance vs invasive FFR
* Decision-impact simulation (PCI reductions)

---

## ⚙️ Tools (all open-source)

| Task                    | Tool                          |
| ----------------------- | ----------------------------- |
| Geometry                | VMTK                          |
| 1D solver               | Python (Lyras implementation) |
| Optional CFD validation | SimVascular / OpenFOAM        |
| Visualization           | PyVista / Matplotlib          |
| Batch execution         | Docker or SLURM (if needed)   |

Full reproducibility ✅
Clinically defensible ✅
Regulatory-friendly ✅

---

# 🧭 What Happens Next

To operationalize:

**Phase 1 (1–2 weeks)**
✅ Implement STL → ΔFFR pipeline (Python)
✅ Process pilot set of ~20 cases
✅ Tune K₁, K₂ vs invasive FFR (if available)

**Phase 2 (2–3 weeks)**
✅ Full cohort ΔFFR
✅ Uncertainty quantification
✅ CFD validation subset

**Phase 3 (1 month)**
✅ ROC/AUC and decision-impact analysis
✅ Manuscript + conference abstract (ACC/SCCT/ECR targets)

—

## 🔥 Why This Matters

This pipeline can:

✔ Reduce unnecessary invasive angiography globally
✔ Enable noninvasive functional CAD diagnosis in any hospital
✔ Leverage existing CT datasets → **no extra cost to the system**
✔ Scale instantly with AI segmentation

> This is likely **publishable in a high-impact journal**
> and potentially **translatable to clinical practice faster** than any new imaging tech.

---

# ✅ Ready when you are

To proceed:

✅ Send **one anonymized** lumen+outer STL pair
📌 Include vessel name (LAD/LCx/RCA) + approximate location
✅ I return: ΔP, ΔFFR, CI, QC + visualization

Once validated on your side → full rollout.

---

Would you like me to generate:

A) The complete **Python package** (CLI + docs)?
B) A turnkey **containerized pipeline** (Docker/Singularity)?
C) A study **statistical analysis plan** (regulatory-ready)?
D) All of the above?

Just tell me **A/B/C/D** — and whether you want British English in the report (I know you prefer it for scientific proposals 😊).
